The trafficking of natural killer cells

Immunological Reviews

Volumn 220, Issue 1, 2007, Pages 169-182

  Grégoire, Claude ^a,b,c   Chasson, Lionel ^a,b,c   Luci, Carmelo ^a,b,c   Tomasello, Elena ^a,b,c   Geissmann, Frédéric ^b   Vivier, Eric ^a,b,c,d   Walzer, Thierry ^a,b,c  

^a CENTRE D IMMUNOLOGIE DE MARSEILLE LUMINY   (France)

^b INSERM   (France)

^c CNRS   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Anatomy of the immune system; Innate immunity; Natural killer cells

Indexed keywords

CELL MARKER; CHEMOKINE; INTEGRIN;

BONE MARROW CELL; CELL DEATH; CELL DIFFERENTIATION; CELL MATURATION; CELL MIGRATION; CELL STRESS; CHEMOTAXIS; HEPATITIS; HUMAN; IMMUNE SYSTEM; INFECTION CONTROL; INNATE IMMUNITY; LYMPH NODE; LYMPHOID ORGAN; MICROBIAL PEST CONTROL; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; STEADY STATE; TISSUE DISTRIBUTION;

ANIMALS; CELL MOVEMENT; HUMANS; KILLER CELLS, NATURAL; MICE; RECEPTORS, IMMUNOLOGIC;

EID: 35748950110     PISSN: 01052896     EISSN: 1600065X     Source Type: Journal    
DOI: 10.1111/j.1600-065X.2007.00563.x     Document Type: Review

References (113)

1. Moretta A, Bottino C, Mingari MC, Biassoni R, Moretta L. What is a natural killer cell? Nat Immunol 2002 3 : 6 8.
2. Raulet DH. Interplay of natural killer cells and their receptors with the adaptive immune response. Nat Immunol 2004 5 : 996 1002.
3. Cerwenka A, Lanier LL. Ligands for natural killer cell receptors: redundancy or specificity. Immunol Rev 2001 181 : 158 169.
4. Vilches C, Parham P. KIR: diverse, rapidly evolving receptors of innate and adaptive immunity. Annu Rev Immunol 2002 20 : 217 251.
5. Vivier E, Nunès JA, Vély F. Natural killer cell signaling pathways. Science 2004 306 : 1517 1519.
6. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989 47 : 187 376.
7. Reynolds CW, Timonen T, Herberman RB. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells. J Immunol 1981 127 : 282 287.
8. Colucci F, Caligiuri MA, Di Santo JP. What does it take to make a natural killer? Nat Rev Immunol 2003 3 : 413 425.
9. Masopust D, Vezys V, Marzo AL, Lefrancois L. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001 291 : 2413 2417.
10. Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol Today 1996 17 : 522 525.
11. Norris S, et al. Resident human hepatic lymphocytes are phenotypically different from circulating lymphocytes. J Hepatol 1998 28 : 84 90.
12. Ferlazzo G, et al. The abundant NK cells in human secondary lymphoid tissues require activation to express killer cell Ig-like receptors and become cytolytic. J Immunol 2004 172 : 1455 1462.
13. Moffett-King A. Natural killer cells and pregnancy. Nat Rev Immunol 2002 2 : 656 663.
14. Ebert LM, Meuter S, Moser B. Homing and function of human skin {gamma}{delta} T cells and NK cells: relevance for tumor surveillance. J Immunol 2006 176 : 4331 4336.
15. Hunger RE, Yawalkar N, Braathen LR, Brand CU. The HECA-452 epitope is highly expressed on lymph cells derived from human skin. Br J Dermatol 1999 141 : 565 569.
16. Buentke E, et al. Natural killer and dendritic cell contact in lesional atopic dermatitis skin - Malassezia-influenced cell interaction. J Invest Dermatol 2002 119 : 850 857.
17. O'Leary JG, Goodarzi M, Drayton DL, von Andrian UH. T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat Immunol 2006 7 : 507 516.
18. Cameron AL, Kirby B, Fei W, Griffiths CE. Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res 2002 294 : 363 369.
19. Gilhar A, et al. Psoriasis is mediated by a cutaneous defect triggered by activated immunocytes: induction of psoriasis by cells with natural killer receptors. J Invest Dermatol 2002 119 : 384 391.
20. Ottaviani C, Nasorri F, Bedini C, de Pita O, Girolomoni G, Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol 2006 36 : 118 128.
21. Eiras P, et al. Intestinal intraepithelial lymphocytes contain a CD3- CD7+ subset expressing natural killer markers and a singular pattern of adhesion molecules. Scand J Immunol 2000 52 : 1 6.
22. Leon F, Roldan E, Sanchez L, Camarero C, Bootello A, Roy G. Human small-intestinal epithelium contains functional natural killer lymphocytes. Gastroenterology 2003 125 : 345 356.
23. Tagliabue A, Befus AD, Clark DA, Bienenstock J. Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med 1982 155 : 1785 1796.
24. Tagliabue A, Luini W, Soldateschi D, Boraschi D. Natural killer activity of gut mucosal lymphoid cells in mice. Eur J Immunol 1981 11 : 919 922.
25. Thapa M, Kuziel WA, Carr DJ. Susceptibility of CCR5-deficient mice to genital herpes simplex virus type 2 is linked to NK cell mobilization. J Virol 2007 81 : 3704 3713.
26. Ashkar AA, Rosenthal KL. Interleukin-15 and Natural Killer and NKT Cells Play a Critical Role in Innate Protection against Genital Herpes Simplex Virus Type 2 Infection. J Virol 2003 77 : 10168 10171.
27. Gill N, Rosenthal KL, Ashkar AA. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection. J Virol 2005 79 : 4470 4478.
28. Andrews DW, Farrell HE, Densley EH, Scalzo AA, Shellam GR, Degli-Esposti MA. NK1.1+ cells and murine cytomegalovirus infection: what happens in situ? J Immunol 2001 166 : 1796 1802.
29. Bajenoff M, et al. Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. J Exp Med 2006 203 : 619 631.
30. Dokun AO, Chu DT, Yang L, Bendelac AS, Yokoyama WM. Analysis of in situ NK cell responses during viral infection. J Immunol 2001 167 : 5286 5293.
31. Grundy MA, Sentman CL. Immunodeficient mice have elevated numbers of NK cells in non-lymphoid tissues. Exp Cell Res 2006 312 : 3920 3926.
32. Salazar-Mather TP, Ishikawa R, Biron CA. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection. J Immunol 1996 157 : 3054 3064.
33. Walzer T, et al. Identification, activation, and selective in vivo ablation of mouse NK cells via NKp46. Proc Natl Acad Sci USA 2007 104 : 3384 3389.
34. Moretta A. Natural killer cells and dendritic cells: rendezvous in abused tissues. Nat Rev Immunol 2002 2 : 957 964.
35. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force". Blood 2005 106 : 2252 2258.
36. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005 5 : 112 124.
37. Newman KC, Riley EM. Whatever turns you on: accessory-cell-dependent activation of NK cells by pathogens. Nat Rev Immunol 2007 7 : 279 291.
38. Racanelli V, Rehermann B. The liver as an immunological organ. Hepatology 2006 43 : S54 S62.
39. Freud AG, et al. A human CD34(+) subset resides in lymph nodes and differentiates into CD56bright natural killer cells. Immunity 2005 22 : 295 304.
40. Vosshenrich CA, et al. A thymic pathway of mouse natural killer cell development characterized by expression of GATA-3 and CD127. Nat Immunol 2006 7 : 1217 1224.
41. Stewart CA, Walzer T, Robbins SH, Malissen B, Vivier E, Prinz I. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells. Eur J Immunol 2007 37 : 1442 1452.
42. Takeda K, et al. TRAIL identifies immature natural killer cells in newborn mice and adult mouse liver. Blood 2005 105 : 2082 2089.
43. Kim S, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol 2002 3 : 523 528.
44. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol 2006 176 : 1517 1524.
45. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural killer cells. Immunol Rev 2006 214 : 47 55.
46. Romagnani C, et al. CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J Immunol 2007 178 : 4947 4955.
47. Rolstad B, Herberman RB, Reynolds CW. Natural killer cell activity in the rat. V. The circulation patterns and tissue localization of peripheral blood large granular lymphocytes (LGL). J Immunol 1986 136 : 2800 2808.
48. Cooper MA, et al. In vivo evidence for a dependence on interleukin 15 for survival of natural killer cells. Blood 2002 100 : 3633 3638.
49. Prlic M, Blazar BR, Farrar MA, Jameson SC. In vivo survival and homeostatic proliferation of natural killer cells. J Exp Med 2003 197 : 967 976.
50. Ranson T, Vosshenrich CA, Corcuff E, Richard O, Muller W, Di Santo JP. IL-15 is an essential mediator of peripheral NK-cell homeostasis. Blood 2003 101 : 4887 4893.
51. Campbell JJ, et al. Unique subpopulations of CD56+ NK and NK-T peripheral blood lymphocytes identified by chemokine receptor expression repertoire. J Immunol 2001 166 : 6477 6482.
52. Imai T, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997 91 : 521 530.
53. Inngjerdingen M, Damaj B, Maghazachi AA. Human NK cells express CC chemokine receptors 4 and 8 and respond to thymus and activation-regulated chemokine, macrophage-derived chemokine, and I-309. J Immunol 2000 164 : 4048 4054.
54. Inngjerdingen M, Damaj B, Maghazachi AA. Expression and regulation of chemokine receptors in human natural killer cells. Blood 2001 97 : 367 375.
55. Johnston B, Kim CH, Soler D, Emoto M, Butcher EC. Differential chemokine responses and homing patterns of murine TCR alpha beta NKT cell subsets. J Immunol 2003 171 : 2960 2969.
56. Nishimura M, et al. Dual functions of fractalkine/CX3C ligand 1 in trafficking of perforin+/granzyme B+cytotoxic effector lymphocytes that are defined by CX3CR1 expression. J Immunol 2002 168 : 6173 6180.
57. Parolini S, et al. The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood 2007 109 : 3625 3632.
58. Geissmann F, et al. Intravascular immune surveillance by CXCR6+ NKT cells patrolling liver sinusoids. PLoS Biol 2005 3 : e113.
59. Jung S, et al. Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 2000 20 : 4106 4114.
60. Hanna J, Bechtel P, Zhai Y, Youssef F, McLachlan K, Mandelboim O. Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 2004 173 : 6547 6563.
61. Wendt K, Wilk E, Buyny S, Buer J, Schmidt RE, Jacobs R. Gene and protein characteristics reflect functional diversity of CD56dim and CD56bright NK cells. J Leukoc Biol 2006 80 : 1529 1541.
62. Beider K, et al. Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of NOD/SCID mice. Blood 2003 102 : 1951 1958.
63. Abraham M, et al. Enhanced unique pattern of hematopoietic cell mobilization induced by the CXCR4 antagonist 4F-benzoyl-TN14003. Stem Cells 2007 in press.
64. Jiang D, et al. Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J Clin Invest 2004 114 : 291 299.
65. Wald O, et al. IFN-gamma acts on T cells to induce NK cell mobilization and accumulation in target organs. J Immunol 2006 176 : 4716 4729.
66. Widney DP, et al. CXCR3 and its ligands participate in the host response to Bordetella bronchiseptica infection of the mouse respiratory tract but are not required for clearance of bacteria from the lung. Infect Immun 2005 73 : 485 493.
67. -/- mice with experimental autoimmune encephalomyelitis. J Immunol 2006 176 : 4399 4409.
68. Cyster JG. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu Rev Immunol 2005 23 : 127 159.
69. Goetzl EJ, Rosen H. Regulation of immunity by lysosphingolipids and their G protein-coupled receptors. J Clin Invest 2004 114 : 1531 1537.
70. Boos MD, Yokota Y, Eberl G, Kee BL. Mature natural killer cell and lymphoid tissue-inducing cell development requires Id2-mediated suppression of E protein activity. J Exp Med 2007 204 : 1119 1130.
71. Frey M, et al. Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 1998 161 : 400 408.
72. Chen S, Kawashima H, Lowe JB, Lanier LL, Fukuda M. Suppression of tumor formation in lymph nodes by L-selectin-mediated natural killer cell recruitment. J Exp Med 2005 202 : 1679 1689.
73. Ferlazzo G, et al. Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc Natl Acad Sci USA 2004 101 : 16606 16611.
74. Mailliard RB, et al. IL-18-induced CD83+CCR7+ NK helper cells. J Exp Med 2005 202 : 941 953.
75. Mazo IB, et al. Bone marrow is a major reservoir and site of recruitment for central memory CD8+ T cells. Immunity 2005 22 : 259 270.
76. Andre P, et al. Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin. Proc Natl Acad Sci USA 2000 97 : 3400 3405.
77. Ohmori K, et al. Differentiation-dependent expression of sialyl stage-specific embryonic antigen-1 and I-antigens on human lymphoid cells and its implications for carbohydrate-mediated adhesion to vascular endothelium. Blood Article 1993 81 : 101 111.
78. Yago T, et al. IL-12 promotes the adhesion of NK cells to endothelial selectins under flow conditions. J Immunol 1998 161 : 1140 1145.
79. Snapp KR, Ding H, Atkins K, Warnke R, Luscinskas FW, Kansas GS. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin. Blood 1998 91 : 154 164.
80. Vivier E, et al. Developmental regulation of a mucinlike glycoprotein selectively expressed on natural killer cells. J Exp Med 1993 178 : 2023 2033.
81. Walcheck B, Moore KL, McEver RP, Kishimoto TK. Neutrophil-neutrophil interactions under hydrodynamic shear stress involve L-selectin and PSGL-1. A mechanism that amplifies initial leukocyte accumulation of P-selectin in vitro. J Clin Invest 1996 98 : 1081 1087.
82. Chen JP, et al. Dengue virus induces expression of CXC chemokine ligand 10/IFN-gamma-inducible protein 10, which competitively inhibits viral binding to cell surface heparan sulfate. J Immunol 2006 177 : 3185 3192.
83. Hokeness KL, Kuziel WA, Biron CA, Salazar-Mather TP. Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver. J Immunol 2005 174 : 1549 1556.
84. Huang D, et al. The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system. FASEB J 2006 20 : 896 905.
85. Khan IA, et al. CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog 2006 2 : e49.
86. Lavergne E, et al. Fractalkine mediates natural killer-dependent antitumor responses in vivo. Cancer Res 2003 63 : 7468 7474.
87. Martin-Fontecha A, et al. Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 2004 5 : 1260 1265.
88. Morrison BE, Park SJ, Mooney JM, Mehrad B. Chemokine-mediated recruitment of NK cells is a critical host defense mechanism in invasive aspergillosis. J Clin Invest 2003 112 : 1862 1870.
89. Salazar-Mather TP, Orange JS, Biron CA. Early murine cytomegalovirus (MCMV) infection induces liver natural killer (NK) cell inflammation and protection through macrophage inflammatory protein 1alpha (MIP-1alpha)-dependent pathways. J Exp Med 1998 187 : 1 14.
90. Stiles LN, Hardison JL, Schaumburg CS, Whitman LM, Lane TE. T cell antiviral effector function is not dependent on CXCL10 following murine coronavirus infection. J Immunol 2006 177 : 8372 8380.
91. Wald O, Weiss ID, Galun E, Peled A. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics. Cytokine 2007 in press.
92. Yu YR, Fong AM, Combadiere C, Gao JL, Murphy PM, Patel DD. Defective antitumor responses in CX3CR1-deficient mice. Int J Cancer 2007 121 : 316 322.
93. Hanna J, et al. Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency. Blood 2005 106 : 3465 3473.
94. Hanna J, et al. CXCL12 expression by invasive trophoblasts induces the specific migration of CD16- human natural killer cells. Blood 2003 102 : 1569 1577.
95. Ramos MV, et al. Involvement of the fractalkine pathway in the pathogenesis of childhood hemolytic uremic syndrome. Blood 2007 109 : 2438 2445.
96. Sentman CL, Meadows SK, Wira CR, Eriksson M. Recruitment of uterine NK cells: induction of CXC chemokine ligands 10 and 11 in human endometrium by estradiol and progesterone. J Immunol 2004 173 : 6760 6766.
97. Tacke F, et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007 117 : 185 194.
98. Tacke F, Randolph GJ. Migratory fate and differentiation of blood monocyte subsets. Immunobiology 2006 211 : 609 618.
99. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999 401 : 708 712.
100. Jin Y, Knudsen E, Wang L, Maghazachi AA. Lysophosphatidic acid induces human natural killer cell chemotaxis and intracellular calcium mobilization. Eur J Immunol 2003 33 : 2083 2089.
101. Pohajdak B, Gomez J, Orr FW, Khalil N, Talgoy M, Greenberg AH. Chemotaxis of large granular lymphocytes. J Immunol 1986 136 : 278 284.
102. Pilaro AM, Sayers TJ, McCormick KL, Reynolds CW, Wiltrout RH. An improved in vitro assay to quantitate chemotaxis of rat peripheral blood large granular lymphocytes (LGL). J Immunol Methods 1990 135 : 213 223.
103. Bottazzi B, Introna M, Allavena P, Villa A, Mantovani A. In vitro migration of human large granular lymphocytes. J Immunol 1985 134 : 2316 2321.
104. Bianchi G, et al. Migration of natural killer cells across endothelial cell monolayers. J Immunol 1993 151 : 5135 5144.
105. Fong AM, et al. Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow. J Exp Med 1998 188 : 1413 1419.
106. Wiltrout RH, et al. Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 1984 160 : 1431 1449.
107. Twilley TA, Mason L, Talmadge JE, Wiltrout RH. Increase in liver-associated natural killer activity by polyribonucleotides. Nat Immun Cell Growth Regul 1987 6 : 279 290.
108. Wang J, Xu JW, Zhang WC, Wei HM, Tian ZG. TLR3 ligand-induced accumulation of activated splenic natural killer cells into liver. Cell Mol Immunol 2005 2 : 449 453.
109. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999 17 : 189 220.
110. Chen Y, Wei H, Gao B, Hu Z, Zheng S, Tian Z. Activation and function of hepatic NK cells in hepatitis B infection: an underinvestigated innate immune response. J Viral Hepat 2005 12 : 38 45.
111. Takeda K, Hayakawa Y, Van Kaer L, Matsuda H, Yagita H, Okumura K. Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc Natl Acad Sci USA 2000 97 : 5498 5503.
112. Guarda G, et al. L-selectin-negative CCR7(-) effector and memory CD8(+) T cells enter reactive lymph nodes and kill dendritic cells. Nat Immunol 2007 8 : 743 752.
113. Walzer T, et al. Natural cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor. Nat Immunol in press.